We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
+2.5%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$6.99B
AUM Growth
-$13.9M
Cap. Flow
-$131M
Cap. Flow %
-1.88%
Top 10 Hldgs %
60.07%
Holding
150
New
17
Increased
52
Reduced
37
Closed
23

Top Buys

Rank Stock Value
1
ST icon
Sensata Technologies
ST
+$183M
2
CI icon
Cigna
CI
+$17.5M
3
COO icon
Cooper Companies
COO
+$16.5M
4
TEVA icon
Teva Pharmaceuticals
TEVA
+$12.3M
5
BABA icon
Alibaba
BABA
+$10.9M

Top Sells

Rank Stock Value
1
PX
Praxair Inc
PX
+$228M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$53.3M
3
VTRS icon
Viatris
VTRS
+$20.6M
4
HDB icon
HDFC Bank
HDB
+$16.9M
5
PFE icon
Pfizer
PFE
+$16.4M

Sector Composition

Rank Sector Weight
1 Financials 33.54%
2 Healthcare 25.68%
3 Communication Services 15.95%
4 Consumer Discretionary 11.33%
5 Industrials 5.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PODD icon
51
Insulet
PODD
$11.7B
$6.6M 0.09%
213,000
+20,000
+10% +$590K
EXAS
52
DELISTED
Exact Sciences
EXAS
$6.54M 0.09%
220,000
– –
DXCM icon
53
DexCom
DXCM
$29.1B
$5.99M 0.09%
299,700
-20,000
-6% -$351K
AERI
54
DELISTED
Aerie Pharmaceuticals
AERI
$5.76M 0.08%
326,503
+235,600
+259% +$4.32M
CERN
55
DELISTED
Cerner Corp
CERN
$5.53M 0.08%
80,078
+16,100
+25% +$1.13M
CPHD
56
DELISTED
Cepheid Inc
CPHD
$5.5M 0.08%
90,000
-15,000
-14% -$855K
IONS icon
57
Ionis Pharmaceuticals
IONS
$9.03B
$5.22M 0.07%
90,700
-7,400
-8% -$471K
LDRH
58
DELISTED
LDR HOLDINGS CORP COM STK
LDRH
$5.06M 0.07%
116,917
-20,000
-15% -$795K
MDVN
59
DELISTED
MEDIVATION, INC.
MDVN
$5.01M 0.07%
87,722
-114,242
-57% -$7.04M
SUPN icon
60
Supernus Pharmaceuticals
SUPN
$2.72B
$4.92M 0.07%
290,000
-90,000
-24% -$1.28M
RLYP
61
DELISTED
RELYPSA INC COM
RLYP
$4.63M 0.07%
140,000
+20,000
+17% +$688K
MDXG icon
62
MiMedx Group
MDXG
$645M
$4.4M 0.06%
380,000
-20,000
-5% -$206K
TSM icon
63
TSMC
TSM
$1.96T
$4.25M 0.06%
187,060
+15,000
+9% +$358K
KERX
64
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$4.19M 0.06%
420,000
-490,302
-54% -$5.26M
NUVA
65
DELISTED
NuVasive, Inc.
NUVA
$4.18M 0.06%
88,160
-15,000
-15% -$701K
ABMD
66
DELISTED
Abiomed Inc
ABMD
$3.94M 0.06%
60,000
-24,888
-29% -$1.65M
SRNE
67
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$3.92M 0.06%
222,301
-40,000
-15% -$514K
ACHC icon
68
Acadia Healthcare
ACHC
$2.56B
$3.92M 0.06%
50,000
– –
MD icon
69
Pediatrix Medical
MD
$2.17B
$3.85M 0.06%
51,962
+17,000
+49% +$1.22M
ACAD icon
70
Acadia Pharmaceuticals
ACAD
$4.45B
$3.77M 0.05%
89,925
– –
ONCE
71
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$3.74M 0.05%
62,000
+25,000
+68% +$1.65M
DVAX
72
DELISTED
Dynavax Technologies
DVAX
$3.68M 0.05%
156,962
+32,000
+26% +$697K
INNL
73
DELISTED
Innocoll Holdings plc Ordinary Shares
INNL
$3.59M 0.05%
245,184
– –
SPNC
74
DELISTED
Spectranetics Corp
SPNC
$3.54M 0.05%
153,956
+30,000
+24% +$838K
EXAM
75
DELISTED
EXAMWORKS GROUP INC COM STK (DE)
EXAM
$3.52M 0.05%
90,000
-14,925
-14% -$614K
1 2
3
4 5

Similar funds

ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return
MA
Mutual Advisors Omaha, Nebraska $4.67B AUM 17.48% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
EI
EFG International Zurich $4.67B AUM
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
LPPI
Local Pensions Partnership Investment London, United Kingdom $4.63B AUM 13.51% 1-Year Est. Return
CCWM
Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return

C WorldWide Group's Q2 2015 Portfolio in Review

As of Q2 2015, C WorldWide Group held 150 positions worth $6.99B, down 0.2% from $7B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

C WorldWide Group's Q2 2015 filing shows 17 new, 52 increased, 37 reduced and 23 closed positions. Its largest new stake was Sensata Technologies: 3,260,860 shares worth $172M. The largest sale was Praxair Inc, an estimated $228M.

By sector, the portfolio is most concentrated in Financials at 34% of assets, up from 33% a quarter earlier, followed by Healthcare and Communication Services.

  • C WorldWide Group's largest Q2 2015 buy was Sensata Technologies: 3,260,860 shares worth $172M.
  • C WorldWide Group added most to Teva Pharmaceuticals in Q2 2015, an estimated $12.3M increase.
  • C WorldWide Group's biggest Q2 2015 reduction was Alphabet (Google) Class C, cutting an estimated $53.3M.
  • C WorldWide Group fully exited Praxair Inc in Q2 2015, selling an estimated $228M.
  • C WorldWide Group's ten largest holdings make up 60% of its $6.99B portfolio in Q2 2015.
  • C WorldWide Group opened 17 new positions and closed 23 in Q2 2015.
  • C WorldWide Group's portfolio value fell 0.2% quarter-over-quarter to $6.99B.

Based on C WorldWide Group's 13F filing for Q2 2015, filed 21 Jul 2015.